XFCH yields 2000000.00% · JNJ yields 2.13%● Live data
📍 XFCH pulled ahead of the other in Year 1
Combined, XFCH + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of XFCH + JNJ for your $10,000?
X-Factor Communications Holdings, Inc. provides interactive digital media network software and services in the United States. The company's flagship application include Digital Screen Control Portal, an interactive real-time digital media communications and broadcast platform that delivers single point publishing of emergency mass notifications, alerts, and rich informational content to various IP endpoint/device. Its solutions also comprise Corporate Communications Control Center, a platform for multi-media, multi-channel, and multi-dimensional internal and external corporate communications; and Marketing and Advertising Control Center for digital media network owners. In addition, the company's products consist of enterprise desktop, storefront and DMAX, multimedia player, and interactive kiosks services. Further, it offers various services consisting of creative services; a suite of professional grade digital media services, including digital media application development, live event production, content creation and management; and digital media Webcasting services that deliver compelling digital media content supporting corporate communications, marketing events, e-commerce, and information distribution services. The company serves healthcare, education, enterprise, transportation, advertising, real estate, retails, public venue, banking and financial, and other sectors. The company was formerly known as Organic Spice Imports, Inc. and changed its name to X-Factor Communications Holdings, Inc. in May 2012. The company was founded in 2005 and is based in Lyndhurst, New Jersey.
Full XFCH Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.